Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment

NCT01564056 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1989

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: HORMONOTHERAPY
DRUG: CHEMOTHERAPY then HORMONOTHERAPY

Sponsor

UNICANCER